Navigation Links
Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2015
Date:2/25/2016

NEW YORK, Feb. 25, 2016 /PRNewswire/ --
Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, "Uremic (Renal) Pruritus Global Clinical Trials Review, H2, 2015" provides an overview of Uremic (Renal) Pruritus clinical trials scenario. This report provides top line data relating to the clinical trials on Uremic (Renal) Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Read the full report: http://www.reportlinker.com/p03638476-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis
2. Zimmer Biomet Holdings to Present at Barclays Global Healthcare Conference
3. Global Extracorporeal Membrane Oxygenation (ECMO) System Market Projected to be a USD 299.2 million Market by 2021, at a developing CAGR of 4.0%
4. Blood Filter Market Global and China Analysis for 2016-2021
5. Global Animal Parasiticides Market Value of USD 9.75 Billion by 2020 - Analysis, Trends and Opportunities Report 2016-2020 - Key Vendors: Boehringer Ingelheim, Merck & Co, Zoetis
6. Polymerase Chain Reaction (PCR) - Products/Tools - Global Trends, Estimates and Forecasts, 2014-2020
7. Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2016
8. Global Systemic Lupus Erythematosus Partnering 2010 to 2016
9. Vascular Closure Devices (VCD) Global Market 2016 - Forecasts to 2022 - Increasing Catheterization Related Procedures a Market Driver
10. Otsuka Announces Worldwide Access Plan for Delamanid with Stop TB Partnerships Global Drug Facility
11. Global Biopharmaceutical Bioseparation Systems Market Report 2016-2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2019)... ... ... in complex industries, a former Procter & Gamble Vice President learned that just knowing his ... turned a make-it-or-break-it opportunity — debating his company’s biggest critic on live TV — into ... September 9, 2019 at 12pm EDT (5pm BST/UK), join 3D Executive Communications expert ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... Spiro Khoury, M.D., will join its Richardson, Texas location, starting Monday, Sep. 2nd. ... of Anesthesiology with a subspecialty board certification in pain management. , Dr. Khoury ...
(Date:8/17/2019)... , ... August 17, 2019 , ... ... Inc. 5000 , Foster Crown, LLC Ranks No. 2502 on the 2019 Inc. ... that Foster Crown, LLC, the boutique physician recruitment firm is No. 2502 on ...
Breaking Medicine Technology:
(Date:8/14/2019)... ... August 15, 2019 , ... R3 Stem Cell ... R3 Stem Cell International is offering regenerative procedures with mesenchymal stem cells performed ... procedure costs only $2950, which includes a complete IV therapy or two joint ...
(Date:8/14/2019)... ... August 13, 2019 , ... Dr. Rachel ... Beauty network. , The Haute Beauty Network, well known for its exclusive and ... leading aesthetic medicine expert and our newest addition to the Haute Beauty members-only ...
(Date:8/14/2019)... (PRWEB) , ... August 13, 2019 , ... New ... P. Falaschi, vice president of operations and information technology, and Elie Goldstein, vice president ... as part of New U Life’s commitment to expanding its corporate governance. , “Since ...
(Date:8/14/2019)... ... August 14, 2019 , ... Today, consumers are taking a harder look ... their physical body, emotions and energy levels. The trick is finding food and beverages ... , That’s why founder Chris Harper created Chase – a delicious, guilt ...
(Date:8/12/2019)... ... August 12, 2019 , ... Cryotherapy has recently been the ... the Oakland Raiders. However, the cause of Brown’s injury was not due to cryotherapy, ... cryotherapy session. Numerous NFL teams, such as the Dallas Cowboys, the Washington Redskins, the ...
Breaking Medicine News(10 mins):